CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
Saved in:
| Title: | CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy. |
|---|---|
| Authors: | Alves WEFM; Nuclear Medicine and Molecular Imaging Department, Barretos Cancer Hospital - Pio XII Foundation, Rua Antenor Duarte Vilela, N° 1331, Barretos, São Paulo, 14784-400, Brazil. wefma@yahoo.com.br.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil. wefma@yahoo.com.br., Bonatelli M; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Dufloth R; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Kerr LM; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Carrara GFA; Surgery Department, Federal University of Triangulo Mineiro, Uberaba, Minas Gerais, Brazil., da Costa RFA; Research and Teaching Institute, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, São Paulo, Brazil., Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Tiezzi D; Department of Gynecology and Obstetrics - Breast Disease Division, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribreirão Preto, São Paulo, Brazil., da Costa Vieira RA; Department of Mastology and Breast Reconstruction, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Pinheiro C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, São Paulo, Brazil. |
| Source: | BMC cancer [BMC Cancer] 2019 Dec 03; Vol. 19 (1), pp. 1173. Date of Electronic Publication: 2019 Dec 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-019-6353-2 |
